Litigation for natalizumab
✉ Email this page to a colleague
US Court Litigation for natalizumab
Patent Trial and Appeal Board Cases for natalizumab
Patent | Petitioner | Status | Filing Date | Accorded Filing Date | Patent Owner | Trial Type | Trial Number | Decision Date | Inventor | Document Download |
---|---|---|---|---|---|---|---|---|---|---|
8,349,321 | Swiss Pharma International AG | ⤷ Sign Up | 2016-04-18 | 04-18-2016 | Biogen MA Inc. | Inter partes review | ⤷ Sign Up | 10-17-2016 | David BURKE | ⤷ Sign Up |
8,815,236 | Swiss Pharma International AG | ⤷ Sign Up | 2016-04-18 | 04-18-2016 | Buckley Burke et al | Inter partes review | ⤷ Sign Up | 10-17-2016 | David Burke | ⤷ Sign Up |
8,900,577 | Swiss Pharma International AG et al. | ⤷ Sign Up | 2016-04-18 | 04-18-2016 | Biogen MA Inc. | Inter partes review | ⤷ Sign Up | 10-17-2016 | David Burke | ⤷ Sign Up |
9,518,123 | Miltenyi Biomedicine GmbH et al. | ⤷ Sign Up | 2022-04-12 | 04-12-2022 | Inter partes review | ⤷ Sign Up | 10-11-2022 | ⤷ Sign Up | ||
>Patent | >Petitioner | >Status | >Filing Date | >Accorded Filing Date | >Patent Owner | >Trial Type | >Trial Number | >Decision Date | >Inventor | >Document Download |